Company Search:
Advanced Search
Sponsored Links
Medigen Biotechnology Corporation Company Snapshot
Medigen Biotechnology Corporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medigen Biotechnology with three other companies in this sector in Taiwan: Genomics Biosci &Tech Co Ltd (2017 sales of 439.53 million Taiwanese Dollars [US$14.25 million] ), Taigen Biopharmaceuticals Holdings Ltd (553.21 million Taiwanese Dollars [US$17.94 million] of which 100% was Medical Development), and Sofiva Genomics Co Ltd (423.94 million Taiwanese Dollars [US$13.75 million] ).

Sales Analysis. Medigen Biotechnology reported sales of 457.78 million Taiwanese Dollars (US$14.85 million) for the year ending December of 2017. This represents an increase of 14.5% versus 2016, when the company's sales were 399.89 million Taiwanese Dollars. Sales of Nucleic Acid Test saw an increase that was more than double the company's growth rate: sales were up 32.9% in 2017, from 76.02 million Taiwanese Dollars to 101.00 million Taiwanese Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medigen Biotechnology Corporation
  Stock Performance Chart for Medigen Biotechnology Corporation
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 67.00
(Figures in Taiwanese Dollars)
1 Week n/a   13 Weeks 26.7%  
4 Weeks 67.5%   52 Weeks 111.0%  
Medigen Biotechnology Corporation Key Data:
  Ticker: 3176 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 457,776,000
(Year Ending Jan 2018).
Employees: 67
  Currency: Taiwanese Dollars Market Cap: 9,291,935,200
  Fiscal Yr Ends: December Shares Outstanding: 138,685,600
  Share Type: Gu Closely Held Shares: 40,242,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.